EXHIBIT 10.10.2] THIS WARRANT AND THE SHARES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. EXCEPT AS OTHERWISE SET FORTH HEREIN OR IN A SECURITIES PURCHASE AGREEMENT DATED AS OF APRIL...Warrant Agreement • August 25th, 2006 • Med Gen Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 25th, 2006 Company Industry Jurisdiction
EXHIBIT 10.16.1] REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of February 23, 2006, by and among Med Gen, Inc., a Nevada corporation with its headquarters located at 7284 W. Palmetto Park Road, Suite 207,...Registration Rights Agreement • August 25th, 2006 • Med Gen Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 25th, 2006 Company Industry Jurisdiction
EXHIBIT 10.7.1] SECURITIES PURCHASE AGREEMENT SECURITIES PURCHASE AGREEMENT (this "Agreement"), dated as of February 23, 2006, by and among Med Gen, Inc., a Nevada corporation, with headquarters located at 7284 W. Palmetto Park Road, Suite 207, Boca...Securities Purchase Agreement • August 25th, 2006 • Med Gen Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 25th, 2006 Company Industry Jurisdiction
EXHIBIT 10.18.2] [To be reprinted on Company letterhead] April 21, 2006 Ladies and Gentlemen: Med Gen, Inc., a Nevada corporation (the "Company"), and certain investors (the "Investors") have entered into a Securities Purchase Agreement dated as of...Securities Purchase Agreement • August 25th, 2006 • Med Gen Inc • Pharmaceutical preparations
Contract Type FiledAugust 25th, 2006 Company IndustryMed Gen, Inc., a Nevada corporation (the "Company"), and certain investors (the "Investors") have entered into a Securities Purchase Agreement dated as of April 21, 2006 (the "Agreement") providing for the issuance of 8% Callable Secured Convertible Notes in the aggregate principal amount of $750,000 (the "Notes") and warrants to purchase an aggregate of 30,000,000 shares of the Company's Common Stock (the "Warrants"), for the aggregate consideration of $750,000.